NCT06233877View on ClinicalTrials.gov

Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Pancreatic Cancer
Interventions
DRUG

G-GLIP plus Mitomycin C

G-FLIP: Gemcitabine, Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin plus Mitomycin C

Trial Locations (1)

11206

Hirscheld Oncology, Brooklyn

Sponsors
All Listed Sponsors
lead

Hirschfeld Oncology

OTHER_GOV

NCT06233877 - Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer | Biotech Hunter | Biotech Hunter